Immunizations

Influenza Vaccine Comparisons

Compare and contrast influenza vaccines currently available for the 2013-2014 flu season including indicated ages, allergies, and how supplied.

Influenza Vaccine Dosing Algorithm: 6 Months-8 Years of Age

Influenza vaccine dosing algorithm for children 6 months to 8 years of age.

Influenza Vaccine Recommendations: Egg Allergies

Influenza vaccine recommendations for individuals who report an allergy to eggs.

CDC: Updated Influenza Vaccination Recommendations for 2018-2019

CDC: Updated Influenza Vaccination Recommendations for 2018-2019

By

In general, routine annual vaccination is recommended for all patients ≥6 months of age who have no contraindications.

2018 Vaccination Schedule: Adults

This schedule indicates the recommended age groups and medical indications for routine administration of currently licensed vaccines for persons 19 years and older.

2018 Catch-Up Vaccination Schedules: 4 Months-18 Years

A catch-up immunization schedule for children 4 months to 18 years of age, including minimum intervals between doses of delayed immunizations.

2018 Vaccination Schedule: 0-18 Years of Age

This schedule indicates the recommended ages for routine administration of currently licensed childhood vaccines for children 0-18 years of age.

Vaccination Schedule: HIV-Infected 0-6 Years of Age

Recommended vaccination schedule for HIV-infected children ages 0 to 6 years old.

Vaccination Schedule: HIV-Infected Adults

Vaccination schedule for HIV-infected adults.

Repeat Influenza Vaccination Yields Reduced Antibody Response

Repeat Influenza Vaccination Yields Reduced Antibody Response

By

Health care workers who had multiple annual vaccinations for influenza demonstrated lower serologic responses to the most current vaccination compared with those who had less than 2 previous vaccinations.

 Improving Seasonal Influenza Vaccine Efficacy in Patients With RA

Improving Seasonal Influenza Vaccine Efficacy in Patients With RA

By

Temporarily stopping methotrexate in patients with rheumatoid arthritis improves the efficacy of seasonal influenza vaccine.

Live Attenuated Influenza Vaccine Does Not Worsen Risk of Asthma

Live Attenuated Influenza Vaccine Does Not Worsen Risk of Asthma

By

Using live attenuated influenza vaccine in young children does not increase risk for exacerbation of asthma.

Novel Adjuvanted H7N1 Vaccine Safe, Immunogenic in Older Adults

Novel Adjuvanted H7N1 Vaccine Safe, Immunogenic in Older Adults

By

The adjuvanted H7N1 vaccine was safe and immunogenic after 2 doses in adults age 65 and older, according to a new study.

Boosting Vaccination Rates Among the Elderly

Boosting Vaccination Rates Among the Elderly

By

A survey presented at the American Academy of Physician Assistants says a healthcare providers vaccination recommendation for elderly patients is greater than media influence.

Low MMR Vaccination Rates in US Adult Travelers

Low MMR Vaccination Rates in US Adult Travelers

More than half of eligible traveling Americans don't get the measles, mumps, rubella vaccine.

Cholera Vaccine Recommendations Issued by ACIP

Cholera Vaccine Recommendations Issued by ACIP

By

Report provides new recommendations and guidance for vaccination providers and travelers about the use of lyophilized CVD 103-HgR (Vaxchora, PaxVax, Redwood City, California).

Pediatric Influenza Armamentarium Bolstered by New Investigational Vaccine

Pediatric Influenza Armamentarium Bolstered by New Investigational Vaccine

By

Seqirus IIV4, an investigational quadrivalent inactivated influenza vaccine, was found to be noninferior to US-licensed comparator IIV4 in children aged 5 to 17 years.

Tdap Vaccine More Effective in Second Trimester of Pregnancy

Tdap Vaccine More Effective in Second Trimester of Pregnancy

By

Maternal vaccination of tetanus-diphtheria-acellular pertussis (Tdap) was found to be more effective in the second rather than the third trimester of pregnancy.

Wide Variation in Flu Vaccination Coverage by Industry and Occupation

Wide Variation in Flu Vaccination Coverage by Industry and Occupation

There was variation in flu vaccination coverage by industry and occupation, with high coverage in the health care industries and occupations.

Vaccination Reduces Influenza-associated Death in Children and Adolescents

Vaccination Reduces Influenza-associated Death in Children and Adolescents

Vaccination reduces influenza-associated death in children with overall effectiveness of 65%.

Maternal Tdap Vaccination Highly Protective Against Infant Pertussis

Maternal Tdap Vaccination Highly Protective Against Infant Pertussis

By

Maternal Tdap vaccination was found to be highly protective against pertussis in newborns.

High-Dose Influenza Vaccine in H3N2 Season More Effective in Seniors

High-Dose Influenza Vaccine in H3N2 Season More Effective in Seniors

By

Compared to infections by H1N1 or influenza B viruses, H3N2 influenza viruses have been associated with higher mortality in older adults.

Quadrivalent Influenza Vaccine Found to be Safe

Quadrivalent Influenza Vaccine Found to be Safe

By

No safety signals associated with the administration of quadrivalent live attenuated influenza vaccine were observed, according to a large population study.

ACIP Issues 2017 Updated Immunization Schedule

ACIP Issues 2017 Updated Immunization Schedule

By

The Advisory Committee on Immunization Practices has issued updated 2017 immunization schedules for for children, adolescents, and adults.

AAP: Better Strategies Needed to Increase Adolescent Vaccination Rates

AAP: Better Strategies Needed to Increase Adolescent Vaccination Rates

According to the American Academy of Pediatrics, HPV and influenza immunization rates remain well below the Healthy People 2020 goals.

Quadracel Vaccine Now Available in the US

Quadracel Vaccine Now Available in the US

By

Quadracel was approved for active immunization against diphtheria, tetanus, pertussis and poliomyelitis in children aged 4 to 6 years old.

Double-Dose Influenza Vaccine Safe, Effective in Young Children

Double-Dose Influenza Vaccine Safe, Effective in Young Children

By

Doubling the standard dose of the inactivated quadrivalent influenza vaccine in children younger than 3 years old had similar efficacy and safety to the standard dose of the vaccine licensed in the United States.

LAIV Safe in Children With Underlying Medical Conditions

LAIV Safe in Children With Underlying Medical Conditions

By

A CDC study found no significant differences in risks of hospitalization following vaccination with LAIV in children who had underlying illnesses compared to healthy children.

FDA Approves Vaxchora for Cholera

FDA Approves Vaxchora for Cholera

By

The CDC's Advisory Committee on Immunization Practices voted unanimously to recommend Vaxchora for US travelers to areas of active cholera transmission.

Vaccination Schedule: HIV-Infected 7-18 Years of Age

Recommended vaccination schedule for HIV-infected children 7 to 18 years old

Sign Up for Free e-newsletters